|Articles|August 26, 2013

Studies Show Great Variation in Contact Precautions

The Centers for Disease Control and Prevention (CDC) recommends placement of patients with a history of methicillin-resistant Staphylococcus aureus (MRSA) and/or vancomycin-resistant enterococcus (VRE) colonization on contact precautions (CP). However, without national guidelines to advise on if or when contact precautions should may be discontinued, hospitals are left to determine for themselves when to remove patients from isolation, if at all.

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Related to this article

Weekly Rounds With Infection Control Today

October 30th, 2026

ICT Weekly Rounds: Ebola Execution Gaps, a Midge-Borne Virus Jumps to Humans, and IDWeek Findings

This week in infection prevention: Kenya’s Bundibugyo virus response shows why execution, not just planning, determines outcomes, and France reported the first known human Shamonda virus infection. Our roundup also covers brucellosis, blood donor screening, and long-acting HIV antibody findings from IDWeek 2026.

October 23rd, 2026

IDWeek 2026: ICU Study Finds Lower Glove Bioburden With PostCare Alcohol Application

An ICU study found that alcohol-based hand rub applied after patient care reduced glove bioburden, while staff raised feasibility concerns. Researchers stress that the practice does not replace glove changes or hand hygiene.

Image of Pathogens flying (Adobe Stock weerasak)

October 6th, 2026

How 3 Decades of SHEA Presidents Shaped the Science and Soul of Infection Prevention

Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.

November 2nd, 2026

David Weber, MD, at IDWeek 2026: A Career of IPC and His Thoughts on Influential Research

Finding infections earlier is only part of the work. At IDWeek 2026, David Weber, MD, MPH, explored how broader surveillance and emerging technologies could help infection preventionists spend more time supporting safer care.

prevent virus and germs health care hygiene concept © Tierney - stock.adobe.com

November 2nd, 2026

Early Flu, Late RSV: What Infection Preventionists Should Watch This Respiratory Season

Two experts give an update ahead of the first season with a new mRNA vaccine against flu.

IDweek 2026 Washington, DC (Adobe Stock)

October 29th, 2026

Jimmy Chang, PhD, Discusses Long-Acting HIV Antibody Therapy at IDWeek 2026

At IDWeek 2026, Jimmy Chang, PhD, discussed investigational HIV antibodies TMB-365 and TMB-380, explaining their complementary mechanisms, early study findings, and ongoing evaluation as a long-acting maintenance regimen.

At IDWeek 2026, Samuel Ntow discussed research finding reactive infection screening markers in 18.3% of replacement donor records from rural Ghana, highlighting opportunities for further evaluation and linkage to care.

October 28th, 2026

Ghana Blood Donor Screening Study: Infection Markers and Findings From IDWeek 2026

At IDWeek 2026, Samuel Ntow, MBChB, MPH, discussed research findings of reactive infection screening markers in 18.3% of replacement donor records from rural Ghana, highlighting opportunities for further evaluation and linkage to care.

Shamonda Virus Vector (midge) in a bottle (Image by author with AI)

October 27th, 2026

What Is Shamonda Virus? First Human Case in France and Implications for Infection Prevention

France’s first reported human Shamonda virus infection raises questions about transmission and vulnerable patients. Explore what investigators know, what remains uncertain, and why infection preventionists should follow this emerging story.